APA

Goyvaerts C., De Groeve K., Dingemans J., Van Lint S., Robays L., Heirman C., Reiser J., Zhang X., Thielemans K., De Baetselier P., Raes G. & Breckpot K. (20130528). Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. : Gene therapy.

Chicago

Goyvaerts C, De Groeve K, Dingemans J, Van Lint S, Robays L, Heirman C, Reiser J, Zhang X-Y, Thielemans K, De Baetselier P, Raes G and Breckpot K. 20130528. Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. : Gene therapy.

Harvard

Goyvaerts C., De Groeve K., Dingemans J., Van Lint S., Robays L., Heirman C., Reiser J., Zhang X., Thielemans K., De Baetselier P., Raes G. and Breckpot K. (20130528). Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. : Gene therapy.

MLA

Goyvaerts C, De Groeve K, Dingemans J, Van Lint S, Robays L, Heirman C, Reiser J, Zhang X-Y, Thielemans K, De Baetselier P, Raes G and Breckpot K. Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. : Gene therapy. 20130528.